Literature DB >> 7559735

Experience of quadrantectomy with axillary dissection without radiotherapy sustained by serial pathological examination for stage I breast cancer.

F Kasumi1, T Iwase, M Yoshimoto, F Akiyama, G Sakamoto.   

Abstract

Breast conserving treatment usually consists of lumpectomy and axillary dissection followed by a limited dose of irradiation so that no significant side-effects occur. However, the precision of lumpectomy depends on the surgical maneuver and pathological evaluation performed at each institution. For this reason, post-operative irradiation to the preserved breast and for the occult carcinoma in the same breast is absolutely mandatory, and effectively becomes a routine step. In 1986, we started to adopt the new breast-conservation method of quadranectomy with axillary dissection for restricted stage I breast cancer without using radiotherapy, at the Cancer Institute Hospital, Tokyo, Japan. As an alternative to irradiation to ensure safety, we chose to administer an elaborate pathological examination on serial sections. The pathological proof has saved troublesome post-operative irradiation, and the results have shown this method to be safe and clear-cut compared to the traditional breast-conserving treatment cited in the literature. From July 1986 to December 1994, we performed 321 cases of quadranectomy and axillary dissection (Q+Ax). If the detailed pathological examination of 5-mm serial sections revealed the stump to be negative, we did not treat the preserved breast with radiotherapy. Out of 321 cases, 247 were analyzed as being stump-negative and of these 235 did not receive radiotherapy at all. During a 5 year 4 month observation period, we have not yet encountered any local recurrence. However, we have experienced 4 cases (1.70%) in which a second cancer developed in the conserved breast. The annual incidence rate was 0.32%. These results are the best so far compared to other published world reports.

Entities:  

Mesh:

Year:  1995        PMID: 7559735     DOI: 10.1007/bf01197768

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  12 in total

1.  Radiation Treatment Volumes and Doses for Patients With Early-Stage Carcinoma of the Breast Treated With Breast-Conserving Surgery and Definitive Irradiation.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1992-04       Impact factor: 5.934

Review 2.  NIH consensus conference. Treatment of early-stage breast cancer.

Authors: 
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

3.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Authors:  U Veronesi; B Salvadori; A Luini; A Banfi; R Zucali; M Del Vecchio; R Saccozzi; E Beretta; P Boracchi; G Farante
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

4.  Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1990-02-21       Impact factor: 13.506

5.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

6.  Late effects of adjuvant radiotherapy for breast cancer.

Authors:  D J Ferguson; H G Sutton; P J Dawson
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

7.  Limited surgery and radiotherapy for early breast cancer.

Authors:  J R Harris; S Hellman; D W Kinne
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

8.  Prognostic factors for local recurrence in breast conservation therapy: residual cancers after lumpectomy.

Authors:  T Fukutomi; H Yamamoto; T Nanasawa; M Itabashi; T Hirota
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

10.  The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.

Authors:  B Fisher; C Redmond; E R Fisher
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

View more
  2 in total

1.  Recent Progress in Breast Conserving Therapy: From Experiences in Japan.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Serial pathological examination of resected specimens as a basic procedure in safe conservative breast cancer treatment.

Authors:  F Kasumi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.